Allegion PLC (ALLE) 2026 Annual Meeting

The proposal asks shareholders to provide a non-binding advisory approval of the compensation of the Company’s named executive officers (NEOs) as disclosed in the Proxy Statement, including the CD&A and compensation tables. Management seeks this advisory endorsement to demonstrate shareholder support for its pay-for-performance program, which includes a mix of base salary, annual cash incentives (AIP), and long-term equity incentives (PSUs, options, RSUs) tied to adjusted EPS, relative TSR and other metrics; these programs are overseen by the Compensation and Human Capital Committee and guided by an independent compensation consultant. The Board recommends a vote FOR, citing alignment of pay with Company performance and governance practices such as clawback policies, share ownership requirements, and capped incentive payouts. Notable context includes strong 2025 financial performance, elevated AIP and PSU payouts (131.31% AIP financial score, PSU payout of 125% for the 2023–2025 period), and the Committee’s responsiveness to shareholder feedback (94% support in 2025). Though advisory and non-binding, the Committee will consider results when making future compensation decisions; potential investor concerns could center on pay magnitude, use of discretion in adjustments, or performance metric selection, but the disclosed program emphasizes alignment and risk mitigants.

The proposal requests that shareholders express a preference for how frequently the non-binding advisory vote on executive compensation should occur: every one, two, or three years, or abstain. The Board recommends an annual vote (one year) to ensure frequent shareholder input; it cites previous strong shareholder support for annual votes. This advisory vote is not binding but will guide the Compensation and Human Capital Committee’s practice. Annual frequency promotes accountability and timely feedback on compensation policies, while some investors argue for less frequent votes to reduce administrative burden. Given the company’s prior 98.4% support in 2020 for annual frequency and ongoing engagement, management recommends a vote for one year.

This management proposal seeks shareholder approval to renew the Board’s authority under Irish law to allot ordinary shares representing up to roughly 20% of the company’s issued share capital for an 18-month period. Management presents this as routine corporate housekeeping necessary to preserve capital-raising flexibility, support equity compensation plan issuances, and facilitate M&A financing when needed. The Board recommends FOR, emphasizing that the authority aligns with Irish market practice and NYSE/SEC protections remain in place. The proposal contains typical safeguards, including an expiry date and allowance for pre-agreements made before expiry.

This special-resolution seeks shareholder approval to disapply statutory pre-emption rights under Irish law for issuances of ordinary shares for cash up to approximately 20% of issued share capital (except in proportionate rights issues), for 18 months. Management frames it as standard practice for Irish PLCS and necessary to facilitate equity compensation plan functioning and corporate finance activities, while noting NYSE and SEC protections. The Board recommends FOR; approval requires a 75% affirmative vote as a special resolution under Irish law.